2018
DOI: 10.1111/epi.14436
|View full text |Cite
|
Sign up to set email alerts
|

The phenotype of bilateral hippocampal sclerosis and its management in “real life” clinical settings

Abstract: The current work describes the phenotypic spectrum of people with pharmacoresistant epilepsy and bilateral HS, highlights salient clinical differences from patients with unilateral HS, and provides a large platform from which to develop further studies, both epidemiological and genomic, to better understand etiopathogenesis and optimal treatment regimes in this condition.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 34 publications
0
5
0
Order By: Relevance
“…There is, however, significant topographic and phenotypic heterogeneity in hippocampal degeneration, creating difficulties in establishing strict criteria for widespread use. Moreover, hippocampal sclerosis is a pathological endpoint associated with various underlying disease processes, including epilepsy, hypoxia, hypoglycaemia, certain infections, and numerous neurodegenerative conditions (Josephs et al , 2007; Thom et al , 2009; Yokota et al , 2010; Malek-Ahmadi et al , 2013; Murray et al , 2013; Ling et al , 2017; Popkirov et al , 2017; Sen et al , 2018). Having originated in a 19th century study of epilepsy by Wilhelm Sommer (Sommer, 1880; Thom, 2009), the term hippocampal sclerosis is still used widely by radiologists and pathologists in the context of seizure disorders (Isnard and Bourdillon, 2015; Thom and Sisodiya, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…There is, however, significant topographic and phenotypic heterogeneity in hippocampal degeneration, creating difficulties in establishing strict criteria for widespread use. Moreover, hippocampal sclerosis is a pathological endpoint associated with various underlying disease processes, including epilepsy, hypoxia, hypoglycaemia, certain infections, and numerous neurodegenerative conditions (Josephs et al , 2007; Thom et al , 2009; Yokota et al , 2010; Malek-Ahmadi et al , 2013; Murray et al , 2013; Ling et al , 2017; Popkirov et al , 2017; Sen et al , 2018). Having originated in a 19th century study of epilepsy by Wilhelm Sommer (Sommer, 1880; Thom, 2009), the term hippocampal sclerosis is still used widely by radiologists and pathologists in the context of seizure disorders (Isnard and Bourdillon, 2015; Thom and Sisodiya, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Another nonspecific histopathologic hallmark that has been associated with dementia, and that is directly related to TDP-43 proteinopathy, is HS pathology. This ill-defined pathologic endpoint has been associated with various underlying disease categories including epilepsy, hypoxia/ anoxia, infectious diseases, and various neurodegenerative conditions [52,[126][127][128]. The term HS is applied in clinical radiology, usually in relation to seizure disorders, and ~90% of PubMed hits for the search term "hippocampal sclerosis" are papers related to seizure disorders.…”
Section: Downstream Effects: Insights and Controversies In An Evolvinmentioning
confidence: 99%
“…In these instances, other regions of archicortex, such as paralimbic cortex or insula, should serve as internal reference. Identification of bilateral pathology will have important treatment consequences, for example, bilateral MTS may preclude surgical resection in many cases 38,39 …”
Section: Hippocampal Digitationsmentioning
confidence: 99%